Author: admin

  • Richard Burden – 2014 Parliamentary Question to the Ministry of Defence

    Richard Burden – 2014 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Richard Burden on 2014-06-11.

    To ask the Secretary of State for Defence, what the acceptable body mass index requirement is for an applicant to the Royal Navy.

    Anna Soubry

    The recommended Body Mass Index (BMI) guidelines for entry into service in the Royal Navy are attached.

    Further assessment is by measurement of waist circumference: males with a BMI over 28 may join if their waist circumference is less than 94cm; females may join if their waist circumference is less than 80 cm.

    The standards do not change during the application process but BMI is measured as part of the medical assessment, and results may differ from a candidates’ individual declaration and/or the outcome of the initial BMI check.

  • Richard Burden – 2014 Parliamentary Question to the Ministry of Defence

    Richard Burden – 2014 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Richard Burden on 2014-06-11.

    To ask the Secretary of State for Defence, whether applicants to the Royal Navy who meet an initial body mass index requirement of 28 face a different check at any other stage of the process.

    Anna Soubry

    The recommended Body Mass Index (BMI) guidelines for entry into service in the Royal Navy are attached.

    Further assessment is by measurement of waist circumference: males with a BMI over 28 may join if their waist circumference is less than 94cm; females may join if their waist circumference is less than 80 cm.

    The standards do not change during the application process but BMI is measured as part of the medical assessment, and results may differ from a candidates’ individual declaration and/or the outcome of the initial BMI check.

  • Richard Burden – 2014 Parliamentary Question to the Department for Transport

    Richard Burden – 2014 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Richard Burden on 2014-06-11.

    To ask the Secretary of State for Transport, when he expects his Department’s review of unpublished datasets to be completed.

    Stephen Hammond

    The Department of Transport completed a comprehensive review of datasets held in August 2013 and this was made available via www.data.gov.uk on 2nd September 2013. This included details of 470 datasets including full metadata for all unpublished datasets.

    “

  • Stephen Timms – 2014 Parliamentary Question to the HM Treasury

    Stephen Timms – 2014 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Stephen Timms on 2014-06-11.

    To ask Mr Chancellor of the Exchequer, what the (a) mean and (b) median age was of people who were registered as self-employed in (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013.

    Mr David Gauke

    The average age of self-employed individuals in the UK is 46 years old. This median age is also 46 years old and these figures are consistent across the three years from 2009-10 to 2011-12.

    These estimates are based on the Survey of Personal Incomes (SPI) for the years concerned. The SPI for 2012-13 will be available later in the year.

  • Luciana Berger – 2014 Parliamentary Question to the Department of Health

    Luciana Berger – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2014-06-11.

    To ask the Secretary of State for Health, for what reasons the policy of NHS England on the number of cycles of IVF it provides to armed forces personnel is to provide fewer than the number recommended by National Institute for Health and Care Excellence.

    Jane Ellison

    NHS England has a number of interim policies in place, including the policy for the provision of in vitro fertilisation (IVF) for Armed Forces personnel.

    A review of the interim policy in relation to the provision of IVF for Armed Forces personnel has recently been undertaken. Following detailed costing of a move to the levels recommended in the National Institute for Health and Care Excellence guideline, it was agreed in May 2014 to increase the number of cycles of IVF to three if clinically appropriate and if eligibility criteria are met.

  • Luciana Berger – 2014 Parliamentary Question to the Department of Health

    Luciana Berger – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2014-06-11.

    To ask the Secretary of State for Health, whether the forthcoming National Institute for Health and Care Excellence quality standard on fertility will be considered for a CCG Outcome Indicator.

    Jane Ellison

    The National Institute for Health and Care Excellence (NICE) has not yet published its final quality standard on fertility. NICE’s Clinical Commissioning Group Outcomes Indicator Set (CCGOIS) Advisory Committee makes recommendations on potential indicators derived from its published guidance and quality standards for inclusion in the CCGOIS which are then considered by NHS England.

  • Luciana Berger – 2014 Parliamentary Question to the Department of Health

    Luciana Berger – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2014-06-11.

    To ask the Secretary of State for Health, what assessment he has made of the (a) prevalence and (b) effect of the sale of the unlicensed drug Melanotan (i) online and (ii) in shops.

    Dr Daniel Poulter

    There are strict legal controls governing the sale and supply of medicinal products in the United Kingdom.

    The Medicines and Healthcare products Regulatory Agency (MHRA) considers Melanotan products to be medicinal products within the meaning of the Human Medicines Regulations 2012 and as such, the manufacture, sale and supply are subject to UK regulatory control. No Melanotan product holds a marketing authorisation (product licence) for use in the UK and consequently advertising and sale or supply would be in breach of regulatory requirements.

    The MHRA is aware that Melanotan is being sold through some outlets such as gyms and beauty salons and is available more widely on the Internet through certain websites.

    During the past 12 months, the MHRA has worked with Internet Service Providers in the UK and abroad to suspend more than 100 websites illegally trading in Melanotan.

    The MHRA issues regular warnings to the public about the dangers involved in the use of unlicensed medicines, including Melanotan and officials have participated in Press campaigns and specific media coverage of the problem.

    As of 12 June 2014, the MHRA has received a total of 22 reports of Adverse Drug Reactions associated with the use of Melanotan (product names Melanotan I, Melanotan II and Ubertan), describing a total of 93 adverse reactions. However, it is important to note that the reporting of a suspected adverse reaction does not necessarily mean it is related to the drug.

  • Luciana Berger – 2014 Parliamentary Question to the Department of Health

    Luciana Berger – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2014-06-11.

    To ask the Secretary of State for Health, what estimate his Department has made of the number of companies who have signed up to one or more pledges set out in the Responsibility Deal; and what estimate he has made of the proportion of those companies which are meeting all of the pledges they have signed up to.

    Jane Ellison

    675 partners are currently signed up the Responsibility Deal. Details of these partners, the pledges they are committed to taking action on and their annual updates are available in full on the Responsibility Deal website at:

    https://responsibilitydeal.dh.gov.uk/partners/

  • Luciana Berger – 2014 Parliamentary Question to the Department of Health

    Luciana Berger – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2014-06-11.

    To ask the Secretary of State for Health, what discussions he has had with the National Clinical Director for Cancer on the performance of the NHS against the waiting time targets for cancer treatment.

    Jane Ellison

    My Rt. Hon. Friend, the Secretary of State for Health, has had a number of discussions with senior members of NHS England’s executive team on the performance of the National Health Service against the waiting time targets for cancer treatment, but not with the National Clinical Director for Cancer.

  • David Winnick – 2014 Parliamentary Question to the Department for Education

    David Winnick – 2014 Parliamentary Question to the Department for Education

    The below Parliamentary question was asked by David Winnick on 2014-06-11.

    To ask the Secretary of State for Education, pursuant to the Answer of 10 June 2014 Official Report, column 74W, on Members: Correspondence, when he expects to send a substantive reply to the letter of 30 April 2014 from the hon. Member for Walsall North about admissions to Walsall Academy which was separate from the letter sent to the Chief Executive of the Education Funding Agency; and for what reason that Answer does not mention that there was separate correspondence on the subject.

    Mr Edward Timpson

    My noble Friend, the Parliamentary Under-Secretary of State for Schools, responded to the hon. Member’s other letter of 30 April about admission arrangements at Walsall academy on 16 June. On behalf of the Department I would like to apologise for the delay in answering this letter.

    My reply of 10 June related to the letter with the reference (2014/0036207) quoted in the question.